Cargando…
Expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and Ki-67 in ductal carcinoma in situ (DCIS) and DCIS with microinvasion
Ductal carcinoma in situ (DCIS) represents a heterogeneous disease in its histologic appearance and biological potential. Some women treated for DCIS subsequently develop invasive breast cancer. DCIS with microinvasion is considered as the interim stage in the progression from DCIS to invasive breas...
Autores principales: | Wan, Zhi-Bin, Gao, Hong-Yi, Wei, Lian, Zhang, An-Qin, Zhang, Jiang-Yu, Wang, Yi, Wang, Dong-Dong, Zhang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221707/ https://www.ncbi.nlm.nih.gov/pubmed/30383678 http://dx.doi.org/10.1097/MD.0000000000013055 |
Ejemplares similares
-
Clinicopathological characteristics and prognostic analysis of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ (DCIS) and DCIS with microinvasion (DCIS-Mi) of the breast
por: Jia, Huiqing, et al.
Publicado: (2022) -
Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer
por: Magnoni, Francesca, et al.
Publicado: (2023) -
Assessment of Ki-67 proliferation index with deep learning in DCIS (ductal carcinoma in situ)
por: Fulawka, Lukasz, et al.
Publicado: (2022) -
Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002) -
The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast
por: Villanueva, Hugo, et al.
Publicado: (2018)